Amgen Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AMGN Nasdaq 2836 www.amgen.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amgen Inc.

Amgen (AMGN) Falls 5.8% as Novo Nordisk Hammers Its Weight Loss Drug Trial - Jun 24th, 2025 12:07 pm
New Amgen obesity drug data disappoint Wall Street - Jun 24th, 2025 5:52 am
2 Small-Cap Stocks Under $10 to Buy With Big Potential - Jun 24th, 2025 5:30 am
Amgen (AMGN) Stock Slides as Market Rises: Facts to Know Before You Trade - Jun 23rd, 2025 4:00 pm
Stocks Rally on Hopes of De-Escalation of Hostilities in the Middle East - Jun 23rd, 2025 2:54 pm
Amgen Shares Fall on Weight-Loss Drug Tummy Troubles - Jun 23rd, 2025 2:15 pm
Amgen stock slips, weight-loss drug moves to phase 3 trial - Jun 23rd, 2025 1:49 pm
RESULTS FROM AMGEN'S PHASE 2 OBESITY STUDY OF MONTHLY MARITIDE PRESENTED AT THE AMERICAN DIABETES ASSOCIATION 85TH SCIENTIFIC SESSIONS - Jun 23rd, 2025 12:31 pm
Amgen gears up for phase 3 trial of monthly weight-loss drug MariTide amid mixed investor sentiment - Jun 23rd, 2025 12:30 pm
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know - Jun 20th, 2025 7:00 am
2 Large-Cap Stocks to Consider Right Now and 1 to Steer Clear Of - Jun 19th, 2025 10:39 pm
Celltrion opens new UK headquarters in Uxbridge, UK - Jun 18th, 2025 8:49 pm
AMGEN'S PHASE 2 MARITIDE DATA TO BE PRESENTED AT THE AMERICAN DIABETES ASSOCIATION 85TH SCIENTIFIC SESSIONS - Jun 18th, 2025 7:00 am
Investing in Amgen (NASDAQ:AMGN) five years ago would have delivered you a 47% gain - Jun 17th, 2025 7:00 am
Amgen’s Strong Cash Flow Supports Reliable Dividend Payments - Jun 16th, 2025 9:13 pm
EHA 2025: Regeneron’s Lynozyfic with Amgen’s Kyprolis combo emerges for R/R MM - Jun 16th, 2025 4:36 am
Amgen Announces Significant Survival Benefit for Lung Cancer Drug IMDELLTRA in Phase 3 Trial - Jun 15th, 2025 3:38 am
BMY Focuses on Label Expansion of Drugs: Will This Revive Growth? - Jun 13th, 2025 7:47 am
Amgen (NASDAQ:AMGN) Has A Pretty Healthy Balance Sheet - Jun 13th, 2025 7:00 am
AMGEN AND FOOTBALL LEGEND BARRY SANDERS HIGHLIGHT DANGERS OF BAD CHOLESTEROL IN NEW DOCUMENTARY - Jun 13th, 2025 7:00 am